You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas: Oncology
21 November 2025 - US-based global healthcare company Abbott (NYSE:ABT) announced on Thursday that it has signed a definitive agreement to acquire molecular diagnostics company Exact Sciences (NASDAQ:...
20 November 2025 - Clinical-stage biopharmaceutical company Nuvalent Inc (Nasdaq:NUVL) said on Wednesday that the US Food and Drug Administration (FDA) has accepted for filing its New Drug Application...
19 November 2025 - Norwegian biotechnology company Hemispherian AS announced on Wednesday that the US Patent and Trademark Office has issued a Notice of Allowance for its patent application covering u...
19 November 2025 - US-based pharmaceutical company AbbVie (NYSE:ABBV) announced on Tuesday that it has received approval from the US Food and Drug Administration for EPKINLY (epcoritamab-bysp), a T-ce...
18 November 2025 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Tuesday that its Phase III lidERA trial of giredestrant met its primary endp...
18 November 2025 - Biotheryx Inc, a biopharmaceutical company focused on the discovery and development of first-in-class protein degraders for cancer and inflammatory diseases, on Monday announced the...
Related Headlines
Henlius and Organon secure first US approval for pertuzumab biosimilar POHERDY
BodyLogicMD supports recommendation to remove black box warnings on certain forms of oestrogen
EirGenix signs second global exclusive licensing deal with Sandoz
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s